Sildenafil / Oxytocin ODT (Each)

Is combination mein sildenafil blood flow badhata hai jabki oxytocin bonding, intimacy, aur emotional connection ko support karta hai. Dono milkar sharirik aur mansik dono tarah ki sehat ko behtar banane mein madad karte hain.

Sildenafil, PDE5 enzyme ko rok kar blood vessels ko relax karta hai, jisse penis mein blood flow badhta hai aur erection mein sahayata milti hai. Dusri taraf oxytocin, jo “bonding hormone” ke naam se jana jata hai, emotional connection ko majboot karta hai, trust aur intimacy badhata hai, aur anxiety ko kam karne mein madadgar hota hai. Dono ka mel sharir aur dimaag ke beech ek santulan banata hai.

Sildenafil / Oxytocin ODT sabke liye surakshit nahi hai. Agar aapko dil se judi koi bimari, low ya high blood pressure, ya hormone-related problem hai to isse lene se pehle doctor se salah lena zaruri hai. Iska use un logon mein avoid karna chahiye jo nitrate ya vasodilator medicines le rahe hain. Kidney ya liver ki gambhir samasya hone par bhi ise saavdhani se lena chahiye. Agar aapko depression, anxiety, ya hormone imbalance hai to apne doctor ko zarur batayen.

Yeh dawa kuch dusri dawaiyon ke saath milkar alag asar dikha sakti hai. Nitrate-based medicines, blood pressure kam karne wali dawaiyan, aur kuch hormonal treatments ke saath iska istemal khatarnak ho sakta hai. Isliye agar aap kisi aur therapy ya supplement par hain to doctor se consultation ke bina iska upyog na karein.

Aksar log is dawa ko achhi tarah tolerate kar lete hain, lekin kuch logon mein halka asar dekhne ko mil sakta hai. Sir dard, muh sookhna, chehre ka lal hona, pet mein jalan, ya halka chakkar aana aam side effects hain. Oxytocin ke karan mood mein achanak badlav, emotional sensitivity, ya neend mein gadbad ho sakti hai. Agar kisi ko chest pain, tez allergic reaction, ya prolonged erection ho to turant medical madad leni chahiye.

Yeh dawa pramukh roop se purushon ke liye design ki gayi hai, isliye pregnancy ya breastfeeding ke dauran iska role bahut simit hai. Agar kisi mahila ko is dawa ke contact mein aana ho ya kisi karan se lena pade to doctor se salah lena zaruri hai. Garbh aur shishu par iske prabhav ko lekar ab tak paryapt research nahi hui hai, isliye bina medical supervision ke iska upyog na karein.

Store this medication at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.

1. Goldstein, I., Burnett, A., Rosen, R.C., Park, P.W., Stecher, V.J.,” The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction”, Sexual Medicine Reviews, vol.7 issue 1, pp. 115-128. 2019. Available: https://www.sciencedirect.com/science/article/pii/S2050052118300830?via%3Dihub– LinkOpens in New Tab
2. McCullough, A.R., “Four-Year Review of Sildenafil Citrate”, Reviews in Urology, vol.4 supp 3, S26 – S38. 2002. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476025/– LinkOpens in New Tab
3. ”Sildenafil citrate”, Prescribers Digital Reference. Available: https://www.pdr.net/drug-summary/?drugLabelId=Viagra-sildenafil-citrate-471– LinkOpens in New Tab
4. ”Sildenafil”, Drug Bank. Available: https://go.drugbank.com/drugs/DB00203– LinkOpens in New Tab
5. Dastjerdi, M.V., Hosseini, S., Bayani, L., “Sildenafil citrate and uteroplacental perfusion in fetal growth restriction”, Journal of Research in Medical Sciences, vol.17 issue 7, pp.632-636. 2012. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685778/– LinkOpens in New Tab
6. Monte, G.L., Graziano, A., Piva, I., Marci, R., “Women taking the “blue pill” (sildenafil citrate): such a big deal?”, Drug Design, Development, and Therapy. Vol.8, pp. 2251-2254. 2014. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232035/– LinkOpens in New Tab
7. Melis MR, Argiolas A. Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances. Int J Mol Sci. 2021 Sep 26;22(19):10376. doi: 10.3390/ijms221910376. PMID: 34638719; PMCID: PMC8509000. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509000/– LinkOpens in New Tab
8. Cleveland Clinic. (2022, March 27). Oxytocin. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/22618-oxytocin#:~:text=In%20people%20assigned%20male%20at%20birth%20(AMAB)%2C%20oxytocin%20plays,sex%20hormone)%20in%20the%20testes.– LinkOpens in New Tab
9. Hemlata Thackare and others, Oxytocin—its role in male reproduction and new potential therapeutic uses, Human Reproduction Update, Volume 12, Issue 4, July/August 2006, Pages 437–448, https://academic.oup.com/humupd/article/12/4/437/2182089– LinkOpens in New Tab
10. Argiolas A (1992) Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action. Ann N Y Acad Sci 12,194–203.
11. Smith, B.P., Babos, M., “Sildenafil”, StatPearls. 2020. Available: https://www.ncbi.nlm.nih.gov/books/NBK558978/– LinkOpens in New Tab
12. Lerman B, Harricharran T, Ogunwobi OO. Oxytocin and cancer: An emerging link. World J Clin Oncol. 2018 Sep 14;9(5):74-82. doi: 10.5306/wjco.v9.i5.74. PMID: 30254962; PMCID: PMC6153127. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153127/#:~:text=Analysis%20of%20serum%20and%20tissue,from%20patients%20without%20prostate%20cancer.– LinkOpens in New Tab
13. Xu H, Fu S, Chen Q, Gu M, Zhou J, Liu C, Chen Y, Wang Z. The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer. Oncotarget. 2017 May 9;8(19):31215-31226. doi: 10.18632/oncotarget.16107. PMID: 28415720; PMCID: PMC5458202. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458202/– LinkOpens in New Tab
14. Kwon Wook Joo and others, Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2, Nephrology Dialysis Transplantation, Volume 19, Issue 10, October 2004, Pages 2480–2486, https://doi.org/10.1093/ndt/gfh413– LinkOpens in New Tab or https://academic.oup.com/ndt/article/19/10/2480/1925723– LinkOpens in New Tab
15. American College of Obstetrics and Gynecology (ACOG). ACOG Practice Bulletin Number 10: Clinical Management Guidelines for Obstetrician-Gynecologists. Induction of labor. Washington, DC: American College of Obstetricians and Gynecologists; November 1999.
16. Mangesi L, Dowswell T. Treatments for breast engorgement during lactation. Cochrane Database Syst Rev. 2010;9:CD006946.
17. Hansten P, Horn J. The Top 100 Drug Interactions: A Guide to Patient Management. includes table of CYP450 and drug transporter substrates and modifiers (appendices). H & H Publications, LLP 2014 edition.
18. Viagra (sildenafil citrate) package insert. New York, NY: Pfizer; 2006 Oct.
19. Cialis (tadalafil) package insert. Indianapolis, IN: Lilly ICOS, LLC; 2011 Oct.
20. Levitra (vardenafil) package insert. Kenilworth, NJ: Schering-Plough; 2007 Mar.
21. Cialis (tadalafil) package insert. Indianapolis, IN: Lilly ICOS, LLC; 2007 Jan.
22. Intelence (etravirine) package insert. Titusville, NJ: Janssen Pharmaceuticals, Inc.; 2014 Aug.
23. Hall MCS, Ahmad S. Interaction between sildenafil and HIV-1 combination therapy. Lancet 1999;353;2071-2.
24. Norvir (ritonavir capsules) package insert. Chicago, IL: AbbVie Inc; 2013 Nov.
25. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/ContentFiles/AdultandAdo– LinkOpens in New Tab
26. Invirase (saquinavir) package insert. South San Francisco, CA: Genentech Inc.; 2012 Nov.
27. Lexiva (fosamprenavir calcium) package insert. Research Triangle Park, NC: ViiV Healthcare; 2013 Apr.
28. Agenerase (amprenavir) package insert. Research Triangle Park, NC: GlaxoSmithKline; 2005 Nov.
29. Reyataz (atazanavir) package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2014 Jun.
30. Prezista (darunavir) package insert. Titusville, NJ: Janssen Pharmaceuticals, Inc.; 2014 Apr.
31. Tybost (cobicistat) package insert. Foster City, CA: Gilead Sciences, Inc; 2014 Sept.
32. Evotaz (atazanavir and cobicistat) tablet package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2015 Jan.
33. Prezcobix (darunavir and cobicistat) tablets package insert. Titusville, NJ: Janssen Therapeutics; 2015 Jan.
34. Merry C, Barry MG, Ryan M, et al. Interaction of sildenafil and indinavir when co-administered to HIV-patients. AIDS 1999;13:F101-7.
35. Kaletra (lopinavir; ritonavir) tablet and solution package insert. North Chicago, IL: AbbVie Inc; 2015 Jan.
36. Viracept (nelfinavir mesylate) package insert. Research Triangle Park, NC: ViiV Healthcare Company; 2013 May.
37. Rescriptor (delavirdine) package insert. La Jolla, CA: Agouron Pharmaceuticals; 2006 Feb.
38. Sustiva (efavirenz) package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2014 May.
39. Walters JS, Woodring JH, Stelling CB, Rosenbaum HD: Salicylate-induced pulmonary edema. Radiology 1983;146:289-293.
40. Hesse C, Siedler H, Burhenne J, et al. Fluvoxamine affects sildenafil kinetics and dynamics. J Clin Psychopharmacol 2005;25:589-92.
41. Balon R. Fluvoxamine-induced erectile dysfunction responding to sildenafil. J Sex Marital Ther 1998;24(4):313-7.
42. Emend capsules (aprepitant) package insert. Whitehouse Station, NJ: Merck & Co., Inc.; 2007 Nov.
43. Zithromax (azithromycin tablets and azithromycin oral suspension) package insert. New York, NY: Pfizer Inc.; 2004 Jan.
44. Biaxin (clarithromycin) package insert. North Chicago, IL: AbbVie, Inc.; 2015 Jan.
45. Vaprisol (conivaptan hydrochloride injection). Deerfield, IL: Astellas Pharma US, Inc.; 2007 Feb.
46. Cardizem LA (diltiazem) package insert. Mississauga, ON: Biovail Corporation; 2006 Apr.
47. Gleevec (imatinib mesylate) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2008 Dec.
48. Diflucan (fluconazole) package insert. New York, NY. Pfizer; 2004 Aug.
49. ProzacR (fluoxetine hydrochloride). Indianapolis, IN: Eli Lilly and Company; 2003 Nov.
50. Serzone (nefazodone) package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2003 Sep.
51. Quinidex Extentabs (quinidine sulfate extended-release tablets) package insert. Richmond, VA: A.H. Robbins Company; 2000 Sept.
52. Ranexa (ranolazine extended-release tablets) package insert. Foster City, CA: Gilead Sciences, Inc. 2013 Dec.
53. Zagam (sparfloxacin) package insert. Research Triangle Park, NC: Bertek Pharmaceuticals; 2003 Feb.
54. Calan (verapamil tablets) package insert. Chicago, IL: GD Searle LLC; 2003 Jul.
55. VFEND (voriconazole) package insert. New York,NY: Pfizer Inc; 2008 Mar.
56. Accolate (zafirlukast) package insert. Wilmington, DE: AstraZeneca; 2004 Jul.
57. ZyfloT Filmtab (zileuton) package insert. Chicago, IL: Abbott Laboratories; 1998 Mar.
58. Tracleer (bosentan) package insert. South San Francisco, CA: Actelion Pharmaceuticals US, Inc.; 2007 Feb.
59. Tegretol (carbamazepine) package insert. East Hanover, NJ. Novartis Pharmaceuticals; 2003 Sept.
60. Phenytoin package insert. Morgantown, WV: Mylan Pharmaceuticals; 1998 Sep.
61. Cerebyx (fosphenytoin sodium) package insert. New York, NY: Parke-Davis; 2002 Jun.
62. Viramune (nevirapine) package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2008 Jun.
63. Finch CK, Chrisman CR, Baciewicz AM, et al. Rifampin and rifabutin drug interactions: an update. Arch Intern Med 2002;162:985-92.
64. Mycobutin (rifabutin) package insert. Kalamazoo, MI:Pharmacia & Upjohn, Co.; 2001 Nov.
65. Rifampin Injection package insert. Bedford, OH: Bedford Laboratories; 2000 Nov.
66. Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin [rifampin]. Clin Pharmacokinet 2003;42:819-50.
67. Rezulin (troglitazone) package insert. Morris Plains, NJ: Parke-Davis; 1999 June. NOTE: Troglitazone was removed from the US market in response to FDA concerns in March 2000.
68. Propulsid (cisapride) package insert. Titusville, NJ; Janssen Pharmaceutica; 2000 Jan. NOTE: As of May 2000; Propulsid has only been available in the United States via an investigational limited access program to ensure proper patient screening and pres
69. Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 2000;39:49-75.
70. Mifeprex (mifepristone, RU-486) package insert. New York, NY: Danco Laboratories, LLC; 2009 Apr.
71. Korlym (mifepristone) tablet package insert. Menlo Park, CA: Corcept Therapeutics Incorporated; 2013 Jun.
72. Christ B, Brockmeier D, Hauck EW, et al. Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. Urology. 2001 Oct;58(4):589-93.
73. De Rose AF, Giglio M, Traverso P, et al. Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy. Int J Impot Res 2002;14:50-3.
74. Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 2002;71:21-9.
75. Goldmeier D. Prolonged erections produced by dihydrocodeine and sildenafil. Br Med J 2002;324:1555. Letter.
76. NardilR (phenelzine) package insert. New York, NY: Pfizer; 2003.
77. ParnateR (tranylcypromine) package insert. Research Triangle Park, NC: GlaxoSmithKline; 2001 Aug.
78. Casper F, Petri E. Local treatment of urogenital atrophy with an estrodiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:171-6
79. Adalat CC (nifedipine extended-release tablets) package insert. West Haven, CT: Bayer Pharmaceuticals Corporation; 2010 Aug.
80. Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir) package insert. Foster City, CA: Gilead Sciences, Inc; 2014 Dec.
81. Pitocin® (oxytocin injection, USP) package insert. Rochester, MI: Monarch Pharmaceuticals; 2003 Jan.
82. Halothane, USP package insert. North Chicago, IL: Abbott Laboratories; 1998 Mar.
83. Pitocin (oxytocin) package insert. Rochester, MI: JHP Pharmaceuticals, LLC; 2014 Sept.
84. Curless RV, Beaumont DM, Sinar EJ, et al. Subarachnoid hemorrhage mimicking acute water intoxication during labour augmented by oxytocin infusion. Br J Clin Pract 1990;44(12):637-638.